Pharmaceutical

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.

Feb 2, 2024 - 18:00
Scottish company secures £4.2m to advance 3D-printed micro-tumour tech
Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.
Read the original article

Tags:

Previous Article

As England’s virus hospitalisations surge flu vaccines evolve

Next Article

LimmaTech secures funding for vaccine technology development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA date

FDA will not meet ahead of bluebird bio’s sickle cell d...

Aug 16, 2023

Inflationary pressure causes drop-off in contract manufacturing M&A

Inflationary pressure causes drop-off in contract manuf...

Jul 29, 2023

STAT+: ImmunoGen drug prolongs survival of women with advanced ovarian cancer

STAT+: ImmunoGen drug prolongs survival of women with a...

Jun 4, 2023